The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly
schedule in a pilot clinical trial.
Please contact site for information.
Principal InvestigatorRichard Schottenfeld, M.D.Yale University
New Haven, Connecticut 06519United StatesThere is no listed contact information for this specific location.Site Status: N/A
| All trademarks are property of their legal owners. | All Rights Reserved
ClinicalConnection.com is a resource that provides information on clinical trials conducted worldwide.
ClinicalConnection.com does not conduct or endorse clinical trials. Please consult your physician before participating.
© All Rights Reserved.
Terms of Service